Your session is about to expire
← Back to Search
Procedure
Lung Resection with Lung Resection Marker Locator Kit for Lung Disease
Phase 1 & 2
Waitlist Available
Research Sponsored by Navigation Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 day
Awards & highlights
Study Summary
This trial is for people with lung nodules who are eligible for surgery. The Lung Resection Marker Locator Kit will help the surgeon find and remove the nodule during surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To compare the measurements from the J-bar fiducial to the first staple line obtained by the device in vivo to that performed in the frozen section room on the lung specimen obtained (which includes both the J bar and the staple line).
Secondary outcome measures
demonstrate safe surgical remove of lung nodule
time required for device placement
whether coefficient is needed
Trial Design
1Treatment groups
Experimental Treatment
Group I: VATS resection with J-barExperimental Treatment1 Intervention
Each patient with a lung nodule meeting criteria will undergo a lung resection which could be one of three approaches: iVATS with Dyna-CT, VATS, or open. Each approach will use a the experimental device the Lung Resection Marker Locator Kit
Find a Location
Who is running the clinical trial?
Navigation Sciences, Inc.Lead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not planning to have surgery on your lungs.
Research Study Groups:
This trial has the following groups:- Group 1: VATS resection with J-bar
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are applications for participation still being accepted for this research endeavor?
"Clinicaltrials.gov states that this trial, first posted on June 3rd 2021 and last updated September 27th 2022, is not presently enrolling patients. However, there are 284 other active studies currently seeking participants to join their trials."
Answered by AI
Share this study with friends
Copy Link
Messenger